301 related articles for article (PubMed ID: 16332438)
21. Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
Wei L; Shi Q; Bastow KF; Brossi A; Morris-Natschke SL; Nakagawa-Goto K; Wu TS; Pan SL; Teng CM; Lee KH
J Med Chem; 2007 Jul; 50(15):3674-80. PubMed ID: 17585747
[TBL] [Abstract][Full Text] [Related]
22. Substituted 2,5'-Bi-1H-benzimidazoles: topoisomerase I inhibition and cytotoxicity.
Kim JS; Gatto B; Yu C; Liu A; Liu LF; LaVoie EJ
J Med Chem; 1996 Feb; 39(4):992-8. PubMed ID: 8632422
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological activity of sulfonamide derivatives of epipodophyllotoxin.
Guianvarc'h D; Duca M; Boukarim C; Kraus-Berthier L; Léonce S; Pierré A; Pfeiffer B; Renard P; Arimondo PB; Monneret C; Dauzonne D
J Med Chem; 2004 Apr; 47(9):2365-74. PubMed ID: 15084135
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of pyrroloiminoquinone derivatives.
Passarella D; Belinghieri F; Scarpellini M; Pratesi G; Zunino F; Gia OM; Via LD; Santoro G; Danieli B
Bioorg Med Chem; 2008 Mar; 16(5):2431-8. PubMed ID: 18077173
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors.
Forghieri M; Laggner C; Paoli P; Langer T; Manao G; Camici G; Bondioli L; Prati F; Costantino L
Bioorg Med Chem; 2009 Apr; 17(7):2658-72. PubMed ID: 19297174
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of 2-(methylaminosulfonyl)-1-(arylsulfonyl)hydrazines as anticancer agents.
Ghosh M; Dutta S; Sanyal U
Neoplasma; 1999; 46(4):242-5. PubMed ID: 10613605
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, topoisomerase I inhibitory and cytotoxic activities of chromone derivatives.
Maicheen C; Jittikoon J; Vajragupta O; Ungwitayatorn J
Med Chem; 2013 May; 9(3):329-39. PubMed ID: 23030699
[TBL] [Abstract][Full Text] [Related]
28. Novel quinolines and pyrimido[4,5-b]quinolines bearing biologically active sulfonamide moiety as a new class of antitumor agents.
Alqasoumi SI; Al-Taweel AM; Alafeefy AM; Noaman E; Ghorab MM
Eur J Med Chem; 2010 Feb; 45(2):738-44. PubMed ID: 19944497
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and activity of caffeoyl pyrrolidine derivatives as potential gelatinase inhibitors.
Li YL; Xu WF
Bioorg Med Chem; 2004 Oct; 12(19):5171-80. PubMed ID: 15351400
[TBL] [Abstract][Full Text] [Related]
30. Design, syntheses, and antitumor activity of novel chromone and aurone derivatives.
Huang W; Liu MZ; Li Y; Tan Y; Yang GF
Bioorg Med Chem; 2007 Aug; 15(15):5191-7. PubMed ID: 17524655
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and anticancer evaluation of furfurylidene 4-piperidone analogs.
Jadhav RL; Magdum CS; Patil MV
Arch Pharm (Weinheim); 2014 Jun; 347(6):407-14. PubMed ID: 24623392
[TBL] [Abstract][Full Text] [Related]
32. Novel carbamate derivatives of 4-beta-amino-4'-O-demethyl-4-desoxypodophyllotoxin as inhibitors of topoisomerase II: synthesis and biological evaluation.
Duca M; Arimondo PB; Léonce S; Pierré A; Pfeiffer B; Monneret C; Dauzonne D
Org Biomol Chem; 2005 Mar; 3(6):1074-80. PubMed ID: 15750651
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of imidazol-2-one derivatives as potential antitumor agents.
Xue N; Yang X; Wu R; Chen J; He Q; Yang B; Lu X; Hu Y
Bioorg Med Chem; 2008 Mar; 16(5):2550-7. PubMed ID: 18226907
[TBL] [Abstract][Full Text] [Related]
34. Analogues of distamycin--synthesis and biological evaluation of new aromatic oligopeptides, potential anticancer agents.
Drozdowska D; Rusak M; Bielawski T; Midura-Nowaczek K
Acta Pol Pharm; 2009; 66(6):633-8. PubMed ID: 20050527
[TBL] [Abstract][Full Text] [Related]
35. Total synthesis and anticancer activity of highly potent novel glycolipid derivatives.
Jung M; Lee Y; Moon HI; Jung Y; Jung H; Oh M
Eur J Med Chem; 2009 Aug; 44(8):3120-9. PubMed ID: 19342127
[TBL] [Abstract][Full Text] [Related]
36. The structure-based design, synthesis, and biological evaluation of DNA-binding amide linked bisintercalating bisanthrapyrazole anticancer compounds.
Hasinoff BB; Zhang R; Wu X; Guziec LJ; Guziec FS; Marshall K; Yalowich JC
Bioorg Med Chem; 2009 Jul; 17(13):4575-82. PubMed ID: 19457675
[TBL] [Abstract][Full Text] [Related]
37. Some new aryl-sydnones: effects on murine tumours.
Grynberg N; Gomes R; Shinzato T; Echevarria A; Miller J
Anticancer Res; 1992; 12(3):1025-8. PubMed ID: 1320354
[TBL] [Abstract][Full Text] [Related]
38. Possible antineoplastic agents: Part XIII. Synthesis, biological evaluation and QSAR studies of some 1-(substituted benzenesulphonyl)-5-oxopyrrolidine-2-carboxylic acid derivatives.
Purkayastha SK; Jha T; Pal DK; De AU
Anticancer Drug Des; 1993 Apr; 8(2):95-100. PubMed ID: 8494605
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of naphthalmustine, a nitrogen mustard derivative of naphthalimide as a rationally-designed anticancer agent.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Qazi GN; Sanyal U
J Exp Clin Cancer Res; 2003 Sep; 22(3):411-8. PubMed ID: 14582700
[TBL] [Abstract][Full Text] [Related]
40. Antitumour drug design: DNA-binding ligands, which inhibit the topoisomerase I.
Pindur U; Lemster T
Pharmazie; 1998 Feb; 53(2):79-86. PubMed ID: 9540103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
